Literature DB >> 16278832

Body dysmorphic disorder and social phobia: cross-sectional and prospective data.

Meredith E Coles1, Katharine A Phillips, William Menard, Maria E Pagano, Christina Fay, Risa B Weisberg, Robert L Stout.   

Abstract

Much attention has been paid to the relationship between body dysmorphic disorder (BDD) and obsessive-compulsive disorder (OCD). However, to our knowledge, no published study has focused directly on the relationship between BDD and social phobia (SP). This is striking given similar clinical features of the two disorders, data showing elevated comorbidity between them, and Eastern conceptualizations of BDD as a form of SP. In this study, 39.3% of 178 individuals with current BDD had comorbid lifetime SP, and 34.3% had current SP. SP onset was typically before BDD. Individuals with BDD, with and without lifetime SP, were similar on many general characteristics (e.g., age of BDD onset, gender distribution, BDD severity, overall functional disability). However, subjects with BDD+SP were significantly less likely to be employed, were more likely to report lifetime suicidal ideation, and had poorer global social adjustment on one of two measures. Both BDD and SP were associated with elevated social anxiety; subjects with BDD+SP experienced additional social anxiety that appeared independent of BDD symptoms. Examining 1-year prospective data available for 161 subjects, BDD+SP subjects were somewhat less likely to experience remission (partial or full) of their BDD symptoms over 1-year follow-up, although this difference was not statistically significant (hazard ratio = .64, P = .18). In summary, these findings, including elevated rates of SP in patients with BDD, highlight a need for additional research on the relationship between BDD and SP. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16278832      PMCID: PMC1397710          DOI: 10.1002/da.20132

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  33 in total

1.  Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.

Authors:  Katharine A Phillips
Journal:  CNS Spectr       Date:  2002-06       Impact factor: 3.790

2.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description.

Authors:  R L Spitzer; J B Williams; M Gibbon; M B First
Journal:  Arch Gen Psychiatry       Date:  1992-08

3.  A 12-month follow-up study of the course of body dysmorphic disorder.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard; Robert L Stout
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

4.  Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale.

Authors:  K M Connor; J R Davidson; L E Churchill; A Sherwood; E Foa; R H Weisler
Journal:  Br J Psychiatry       Date:  2000-04       Impact factor: 9.319

5.  Quality of life for patients with body dysmorphic disorder.

Authors:  K A Phillips
Journal:  J Nerv Ment Dis       Date:  2000-03       Impact factor: 2.254

6.  Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin kyofusho.

Authors:  R A Kleinknecht; D L Dinnel; E E Kleinknecht; N Hiruma; N Harada
Journal:  J Anxiety Disord       Date:  1997 Mar-Apr

7.  Prevalence of body dysmorphic disorder in patients with anxiety disorders.

Authors:  S Wilhelm; M W Otto; B G Zucker; M H Pollack
Journal:  J Anxiety Disord       Date:  1997 Sep-Oct

8.  Personality disorders and traits in patients with body dysmorphic disorder.

Authors:  K A Phillips; S L McElroy
Journal:  Compr Psychiatry       Date:  2000 Jul-Aug       Impact factor: 3.735

9.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06

10.  Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study.

Authors:  O Brawman-Mintzer; R B Lydiard; K A Phillips; A Morton; V Czepowicz; N Emmanuel; G Villareal; M Johnson; J C Ballenger
Journal:  Am J Psychiatry       Date:  1995-11       Impact factor: 18.112

View more
  10 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Cosmetic surgery and psychological issues.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2007-12

Review 3.  Relationship between social anxiety disorder and body dysmorphic disorder.

Authors:  Angela Fang; Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2010-08-14

4.  Rejection sensitivity mediates the relationship between social anxiety and body dysmorphic concerns.

Authors:  Angela Fang; Anu Asnaani; Cassidy Gutner; Courtney Cook; Sabine Wilhelm; Stefan G Hofmann
Journal:  J Anxiety Disord       Date:  2011-06-16

5.  A comparison study of body dysmorphic disorder versus social phobia.

Authors:  Megan M Kelly; Kristy Dalrymple; Mark Zimmerman; Katharine A Phillips
Journal:  Psychiatry Res       Date:  2012-09-19       Impact factor: 3.222

6.  Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting.

Authors:  Michelle Conroy; William Menard; Kathryn Fleming-Ives; Poonam Modha; Hilary Cerullo; Katharine A Phillips
Journal:  Gen Hosp Psychiatry       Date:  2008 Jan-Feb       Impact factor: 3.238

7.  A prospective pilot study of levetiracetam for body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard
Journal:  CNS Spectr       Date:  2009-05       Impact factor: 3.790

Review 8.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 9.  Issues in the assessment of social phobia: a review.

Authors:  Andrea M Letamendi; Denise A Chavira; Murray B Stein
Journal:  Isr J Psychiatry Relat Sci       Date:  2009       Impact factor: 0.481

10.  Cognitive-behavioral therapy for body dysmorphic disorder: a review of its efficacy.

Authors:  Angélica M Prazeres; Antônio L Nascimento; Leonardo F Fontenelle
Journal:  Neuropsychiatr Dis Treat       Date:  2013-02-28       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.